UCSD has initiated a clinical trial to assess Nexalin Technology's Halo Clarity device for treating mTBI and PTSD.

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

Making devices that are defect-free and able to withstand years of harsh environments is made more difficult by a combination ...

StockNews.com upgraded shares of Boston Scientific (NYSE:BSX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday. A number of other equities analysts ...

AI-Generated News Feeds. News aggregation algorithms prioritize stories that elicit strong emotions. This means that content ...

Cognitive function is not just a concern for older age. Your daily habits can significantly influence how your brain performs ...

In the second world war, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...

Just as soldiers may develop post-traumatic stress disorder after facing life-threatening situations, military and police ...

We talk to the experts about how to break free from the trend trap and design classic interiors that will last a lifetime ...

The U.S. Food and Drug Administration (FDA) has announced several significant developments this week, spanning advancements ...

Explore The Genius Wave reviews to uncover user experiences, potential benefits, and complaints to check if it's worth your ...